Novozymes B A/S

NZYM-B 
(NasdaqOMXC) 
 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 250.70 <%= Resources.Global.txtDown %>
Updated 10:38:13
Change % -1.45% Stock price decreasing
Change -3.70 Stock price decreasing
Volume 144,801
High DKK 253.90
Low DKK 250.10
Open DKK 252.80
ISIN DK0060336014
Prev close DKK 254.40
# of shares 256.26M
Market cap 64,243M DKK
Intraday

Novozymes B A/S
Market is open (until 16:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  250.70 0.5% Stock price increasing 3.3% Stock price increasing -12.1% Stock price decreasing -23.3% Stock price decreasing -14.3% Stock price decreasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
14,002
3,884
2,825
11,593
17,791
2014
12,459
3,384
2,526
11,280
18,426
2013
11,746
2,901
2,200
11,066
16,506
2012
11,234
2,745
2,015
9,568
15,113
2011
10,510
2,340
1,828
8,824
13,842
2010
9,724
2,117
1,614
7,836
12,593
2009
8,448
1,688
1,194
5,841
0
2008
8,146
1,504
1,062
4,465
0
2007
7,438
1,481
1,042
3,657
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Archer-Daniels-Midland Company 43.56 -2.0% Stock price decreasing -6.3% Stock price decreasing 4.1% Stock price increasing -0.9% Stock price decreasing 38.2% Stock price increasing -4.6% Stock price decreasing
 
Internationa Flavors & Fragran.. 116.66 1.0% Stock price increasing -1.1% Stock price decreasing -9.6% Stock price decreasing -11.7% Stock price decreasing 1.2% Stock price increasing -1.0% Stock price decreasing
 
Procter & Gamble Company (The) 84.01 0.6% Stock price increasing -0.8% Stock price decreasing -4.3% Stock price decreasing -2.3% Stock price decreasing 12.0% Stock price increasing -0.1% Stock price decreasing
 
KAO Corp 45.05 49.5% Stock price increasing 49.5% Stock price increasing 49.5% Stock price increasing 49.5% Stock price increasing 49.5% Stock price increasing 49.5% Stock price increasing
 
Givaudan SA NA SF 10 1,701.15 36.5% Stock price increasing 36.5% Stock price increasing 36.5% Stock price increasing 36.5% Stock price increasing 36.5% Stock price increasing 36.5% Stock price increasing
 
Reckitt Benckiser Group PLC OR.. 6,904.00 1.8% Stock price increasing 4.4% Stock price increasing -6.2% Stock price decreasing -7.6% Stock price decreasing 14.9% Stock price increasing 0.3% Stock price increasing
 
Basf SE NA O.N. 87.55 -0.6% Stock price decreasing -0.2% Stock price decreasing 11.8% Stock price increasing 22.0% Stock price increasing 41.6% Stock price increasing -0.9% Stock price decreasing
 
Lonza Group AG NA SF 1 171.65 0.1% Stock price increasing 8.9% Stock price increasing 3.8% Stock price increasing 11.2% Stock price increasing 26.1% Stock price increasing 4.6% Stock price increasing
 
Monsanto Company 107.62 -0.8% Stock price decreasing 2.0% Stock price increasing 5.3% Stock price increasing 4.0% Stock price increasing 18.4% Stock price increasing 2.3% Stock price increasing
 
Syngenta AG NA SF 0,1 393.33 45.4% Stock price increasing 45.4% Stock price increasing 45.4% Stock price increasing 45.4% Stock price increasing 45.4% Stock price increasing 45.4% Stock price increasing
 
DSM KON 57.02 -2.2% Stock price decreasing 0.8% Stock price increasing -3.8% Stock price decreasing 0.8% Stock price increasing 33.3% Stock price increasing 0.1% Stock price increasing
 
Solvay 107.05 -2.1% Stock price decreasing -4.2% Stock price decreasing 3.0% Stock price increasing 24.7% Stock price increasing 32.1% Stock price increasing -3.9% Stock price decreasing
 
Unilever DR 38.60 -0.7% Stock price decreasing 0.9% Stock price increasing -0.9% Stock price decreasing -8.1% Stock price decreasing 4.1% Stock price increasing -1.3% Stock price decreasing
 
Givaudan N 1,825.00 -1.1% Stock price decreasing -0.4% Stock price decreasing -5.5% Stock price decreasing -11.3% Stock price decreasing 3.0% Stock price increasing -2.2% Stock price decreasing
 
Lonza N 182.30 -1.0% Stock price decreasing 7.6% Stock price increasing 0.7% Stock price increasing 8.6% Stock price increasing 22.3% Stock price increasing 3.4% Stock price increasing
 
Syngenta N 422.10 2.1% Stock price increasing 2.2% Stock price increasing 3.0% Stock price increasing 11.5% Stock price increasing 12.2% Stock price increasing 4.9% Stock price increasing
 
Cropenergies AG 5.57 1.6% Stock price increasing 25.5% Stock price increasing 8.0% Stock price increasing 8.5% Stock price increasing 35.8% Stock price increasing 9.3% Stock price increasing
 
Codexis Inc 4.90 -3.0% Stock price decreasing 2.1% Stock price increasing 11.4% Stock price increasing 18.9% Stock price increasing 28.6% Stock price increasing 6.5% Stock price increasing
 
Chr Hansen Holding A/S 402.60 3.6% Stock price increasing 4.1% Stock price increasing 3.7% Stock price increasing -4.0% Stock price decreasing -1.8% Stock price decreasing 2.9% Stock price increasing
Indices Open
 
OMX Copenhagen 20 CAP 1,036.53 0.6% Stock price increasing 3.4% Stock price increasing 2.4% Stock price increasing 2.6% Stock price increasing 9.9% Stock price increasing 1.7% Stock price increasing

Company profile

Novozymes(NZYM) is split in two business divisions: Enzymes Business and BioBusiness. NZYM is the world’s leading player within industrial enzymes with 47% of the global market, which is estimated to be around DKK 19bn in total. Enzymes comprises the largest part of the revenue (2010: 94%, 2009: 92%) and is split into four sub segments of which one is technical enzymes, where sales of enzymes to the bioethanol industry take place (2010 Rev: 19%, mainly from North America). NZYM invests a large part of their R&D costs in development of bioethanol; massive production will however not take place before 2012/13. The largest competitors in this segment are Danisco and DSM. NZYM puts its focus on cost reductions, innovation and efficiency, seeing growth opportunities in the developing world. NZYM has no plans of major acquisitions after having acquired EMD/Merck Crop BioScience in 2011. With over 6,500 granted or pending patents, NZYM aims to achieve long-term organic sales growth of more than 10% p.a (hist.avg.: 8-9%) and increased dividend pay-out ratio to 35% of net profit (curr.: 30%).

Peers

Indices Last Change  
OMX C20 CAP 1,036.53 -0.5% Stock price decreasing
100,4,14,23,29,36,46,44,36,15
Instruments Last Change  
Archer-Danie.. 43.56 0.0% Stock price unchanged
27,75,47,39,17,35,47,37,57,57
Internationa.. 116.66 0.0% Stock price unchanged
0,94,76,86,95,80,78,72,74,75
Procter & Ga.. 84.01 0.0% Stock price unchanged
64,48,60,78,73,73,64,69,89,100
KAO Corp 45.05 2.9% Stock price increasing
0,0,0,0,0,0,0,0,0,0
Givaudan SA .. 1,701.15 -0.4% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
Reckitt Benc.. 6,904.00 -0.7% Stock price decreasing
94,83,68,60,58,49,35,30,29,34
Basf SE NA O.. 87.55 -0.8% Stock price decreasing
87,89,54,19,27,31,17,21,6,14
Lonza Group .. 171.65 0.0% Stock price unchanged
Monsanto Com.. 107.62 0.0% Stock price unchanged
12,42,82,78,73,78,82,96,87,57
Syngenta AG .. 393.33 -0.2% Stock price decreasing
100,100,100,100,100,0,0,0,0,0
DSM KON 57.02 -1.0% Stock price decreasing
100,13,19,19,13,18,16,8,19,16
Solvay 107.05 -0.8% Stock price decreasing
100,15,19,7,30,19,15,7,7,30
Unilever DR 38.60 -0.7% Stock price decreasing
100,83,55,50,59,88,50,16,8,10
Givaudan N 1,825.00 0.0% Stock price unchanged
73,20,26,53,60,66,86,80,73,66
Lonza N 182.30 -0.7% Stock price decreasing
100,23,15,23,23,61,30,0,23,0
Syngenta N 422.10 0.1% Stock price increasing
45,27,39,66,72,81,51,45,45,63
Cropenergies.. 5.57 -2.5% Stock price decreasing
40,75,77,100,50,25,0,60,26,10
Codexis Inc 4.90 0.0% Stock price unchanged
0,0,0,0,0,0,0,0,0,0
Chr Hansen H.. 402.60 -1.1% Stock price decreasing
75,46,31,15,43,46,40,50,21,0

Targets for: Novozymes B A/S

Ritzau Finans
 
Analyst
Target
Date
Novozymes/Deutsche: Indleder dækning med
Deutsche Bank
300
07/10/16
Novozymes/Jefferies: Hæver kursmål til 352 kr. fra 287 kr.
Jefferies
352 op
04/07/16
Novozymes/Carnegie: Kursmålet hæves med 40 kr. til 330 kr.
Carnegie
330
27/04/16
Novozymes/Jyske: Sænker kursmål til 275 kr. fra 320 kr.
Jyske Bank
275 ned
21/01/16

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 January 2017 10:53:15
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170103.1 - EUROWEB7 - 2017-01-17 11:53:15 - 2017-01-17 10:53:15 - 1000 - Website: OKAY